GlassScriptPhysician profile
Christopher J Danner
NPI 1588660625
$2,204.13
in general payments reported to CMS, 2019-2025
14 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $284 · 2021: $346 · 2022: $699 · 2023: $473 · 2024: $130 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $763.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $456.15 | 2021-2022 | |
| Abbvie INC. | $422.33 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $323.15 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Lupin INC. | $245.42 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $218.99 | 2023-2024 | Myfembree |
| Astellas Pharma US INC | $149.52 | 2023 | Veozah |
| Mayne Pharma Commercial LLC | $138.31 | 2025 | |
| Gynesonics, INC. | $128.43 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Ethicon US, LLC | $37.92 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.59 | 2021 | |
| Merck Sharp & Dohme LLC | $17.69 | 2020 | |
| Novo Nordisk INC | $15.59 | 2019 | |
| Organon LLC | $14.85 | 2024 | |
| Exeltis, USA INC. | $13.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Danner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.